Andy Brailo, the Chief Commercial Officer of Premier Inc (PINC, Financial), executed a sale of 8,331 shares of the company on May 20, 2024. The transaction was filed on the same day with the SEC. Following this transaction, the insider's total sales over the past year amount to 8,331 shares, with no recorded purchases.
Premier Inc, a healthcare improvement company, unites an alliance of approximately 4,100 U.S. hospitals and 200,000 other providers to transform healthcare. The company's integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services aim to improve patient outcomes while reducing costs.
On the date of the sale, shares of Premier Inc were priced at $19.64, valuing the transaction at approximately $163,579.64. This pricing places the company's market cap at $2.03 billion.
The price-earnings ratio of Premier Inc stands at 30.28, which is above both the industry median of 25.67 and the company's historical median. This higher ratio suggests a premium valuation compared to industry standards.
According to the GF Value, the intrinsic value of Premier Inc's stock is estimated at $30.73, which, compared to the current price, indicates a price-to-GF-Value ratio of 0.64. This suggests that the stock might be a Possible Value Trap, Think Twice before investing, based on its GF Value assessment.
The insider transaction history for Premier Inc shows minimal activity, with no insider buys and only 2 insider sells over the past year, indicating a possible lack of confidence from insiders towards the stock's current valuation.
Investors and stakeholders in Premier Inc (PINC, Financial) may want to consider these factors and monitor insider activities and market valuations closely to make informed decisions.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
